1.
The Influence of High Fat Diet on the Pharmacokinetics of Controlled Release Aminophylline Tablets
高脂食物对氨茶碱控释片药代动力学的影响
2.
The Investigation of Aminophylline Sustained-release Pellets Made by Fluidized-bed;
流化床法制备氨茶碱缓释微丸的研究
3.
Chemical Modification of Ligustrazine and Bioactivity Tests of Ligustrazine Derivatives;
川芎嗪结构修饰及生物活性测定甘氨酸茶碱纳缓释片不对称给药的药代动力学研究
4.
Clinical observation of Theo-Dur on patients with COPD
茶碱缓释片治疗慢性阻塞性肺疾病的临床观察
5.
Study on preparation and stability of theophylline sustained-release tablets
茶碱缓释片的制备及其初步稳定性考察
6.
Determination of Theophylline in Pulsatile Controlled-release Pellets Capsule of Theophylline by HPLC
HPLC法测定茶碱脉冲控释微丸胶囊中主药的含量
7.
Mucociliotoxicity of theophylline/chitosan/β-cyclodextrin microspheres as a sustained pulmonary delivery
氨茶碱/壳聚糖/β-环糊精肺部缓释微球对呼吸道粘膜的影响
8.
Dose out amino- phylline to an asthmatic patent
给气喘病人服氨茶碱
9.
Core formulation optimization of Osmotically Controlled Release Tablets of colchicine
秋水仙碱渗透泵控释片的片芯处方设计
10.
Factors influencing in vitro release of theophylline from acylated modified chitosan matrix tablets
茶碱酰化改性壳聚糖骨架片体外释药影响因素考察
11.
Buchang Wenxin Granule Combined Theophylline Sustained Release Tablets at Target Dosage in Agee Patients with Sinus Brady-cardia at Target Dosage in Patients with Arrhythmia
步长稳心颗粒与茶碱缓释片联用治疗老年窦性心动过缓疗效观察
12.
Lingyun Baekho tea with caffeine 4.91%, 3.63% amino acids, tea polyphenols 35.6%.
凌云白毫茶含咖啡碱4.91%,氨基酸3.63%，茶多酚35.6%。
13.
2-amino-2-methyl-1-propanol-8- bromotheophyllinate
２－氨基－２－甲基－１－丙醇－８－溴茶碱
14.
Attention to the interaction while using aminophylline combined with other medicines;
氨茶碱与他药合用时应注意相互影响
15.
Aminophylline Protects the renal function in neonates with perinatal asphyxia
氨茶碱对窒息新生儿肾脏的保护作用
16.
Stability of Aminophylline Injection and Furosemide injection in Compatibility Solutions
氨茶碱与呋塞米注射液的配伍稳定性
17.
Synthesis of L-theanine via Ni(Ⅱ) complex of glutamic acid's Schiff base
谷氨酸席夫碱Ni(Ⅱ)配合物法合成L-茶氨酸
18.
The Effects and Mechanism of Theophylline on Mild and Modest Obstructive Sleep Apnea Syndrome(OSAS) and Stable Chronic Obstructive Pulmonary Disease(COPD);
茶碱缓释片治疗轻、中度OSAS及稳定期COPD夜间低氧的疗效观察和作用机制探讨